Altimmune Inc (NASDAQ:ALT) shares, rose in value on Wednesday, April 16, with the stock price down by -2.87% to the previous day’s close as strong demand from buyers drove the stock to $4.40.
Actively observing the price movement in the last trading, the stock closed the session at $4.53, falling within a range of $4.32 and $4.51. The value of beta (5-year monthly) was 0.891. Referring to stock’s 52-week performance, its high was $11.16, and the low was $3.55. On the whole, ALT has fluctuated by -21.57% over the past month.
With the market capitalization of Altimmune Inc currently standing at about $338.86 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 560.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ALT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ALT currently trading nearly -9.51% and -21.56% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.20, while the 7-day volatility ratio is showing 6.80% which for the 30-day chart, stands at 7.86%. Furthermore, Altimmune Inc (ALT)’s beta value is 1.16, and its average true range (ATR) is 0.39.
A comparison of Altimmune Inc (ALT) with its peers suggests the former has fared considerably weaker in the market. ALT showed an intraday change of -2.87% in last session, and over the past year, it shrunk by -41.72%%.
Data on historical trading for Altimmune Inc (NASDAQ:ALT) indicates that the trading volumes over the past 10 days have averaged 2.35 and over the past 3 months, they’ve averaged 2.49 million. According to company’s latest data on outstanding shares, there are 77.01 million shares outstanding.
Nearly 1.04% of Altimmune Inc’s shares belong to company insiders and institutional investors own 53.24% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 21.82 million shares as on 2025-03-31, resulting in a short ratio of 7.14. According to the data, the short interest in Altimmune Inc (ALT) stood at 2856.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 21.67 million. The stock has fallen by -38.97% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALT stock heading into the next quarter.
